MedTrace Logo

Validation of a Health-Related Symptom Index for Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL)

NCT02836522 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 406

Last updated 2023-09-01

No results posted yet for this study

Summary

The purpose of this study is to finalize development of a questionnaire that measures health-related symptoms and concerns for persons diagnosed with, and either treated or monitored for, anal pre-cancer lesions.

Conditions

  • Anal High-Grade Squamous Intraepithelial Lesions

Interventions

BEHAVIORAL

Assessment of Health-Related Quality

Demographic Questionnaire, ANCHOR HRSI, FACT-G, MDASI, Patient ECOG PS, PGIC

Sponsors & Collaborators

Principal Investigators

  • Thomas Atkinson, PhD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-25
Primary Completion
2023-08-31
Completion
2023-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02836522 on ClinicalTrials.gov